Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GEN-003 in Genital HSV-2 Infection
NCT02515175Phase 2Completed
- Sponsor
- Genocea Biosciences
- Start
- Nov 2015
- Primary completion
- Jul 2016
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of GEN-003 in genital herpes, sponsored by Genocea Biosciences. Started Nov 2015; status: completed.
02
Drugs
GEN-003
03
Conditions
genital herpes
Beyond the preview
Go deeper on NCT02515175.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02515175.